Nivolumab Plus Ipilimumab for Previously Treated Stage IV Squamous Cell Lung Cancer. Zhao B, Ma W. JAMA Oncol 2022 Feb 10. pii: 2789076. doi: 10.1001/jamaoncol.2021.7784.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhao B, Ma W. Nivolumab Plus Ipilimumab for Previously Treated Stage IV Squamous Cell Lung Cancer. JAMA Oncol 2022 Feb 10. pii: 2789076. doi: 10.1001/jamaoncol.2021.7784.
PMID: 35142796